LAPATINIB

LAPATINIB was reported 15452 times

LAPATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SKIN CHAPPED 99 0.2450
1 BOTRYOMYCOSIS 7 0.1795
2 TRANSAMINASES 10 0.1695
3 LEUKONYCHIA 8 0.1270
4 NAIL BED INFLAMMATION 38 0.1191
5 HER-2 POSITIVE BREAST CANCER 13 0.0929
6 LIMBAL STEM CELL DEFICIENCY 6 0.0732
7 NASAL MUCOSAL DISORDER 38 0.0652
8 METASTASES TO SKIN 59 0.0571
9 STREPTOCOCCAL SEPSIS 57 0.0481
10 HER2 POSITIVE BREAST CANCER 17 0.0453
11 PERIANAL ERYTHEMA 5 0.0413
12 HORMONE RECEPTOR POSITIVE BREAST CANCER 11 0.0404
13 ANAL ERYTHEMA 5 0.0400
14 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 931 0.0399
15 PARONYCHIA 174 0.0396
16 METASTASES TO CENTRAL NERVOUS SYSTEM 486 0.0376
17 METASTASES TO THE MEDIASTINUM 15 0.0364
18 ONYCHALGIA 34 0.0339
19 BREAST CANCER METASTATIC 361 0.0336
20 LYMPHANGIOSIS CARCINOMATOSA 34 0.0326
21 PSEUDOMONAL SEPSIS 56 0.0319
22 OSTEORADIONECROSIS 7 0.0315
23 NEUTROPHIL COUNT 6 0.0286
24 NAIL BED BLEEDING 16 0.0281
25 SUPERIOR VENA CAVA SYNDROME 16 0.0265
26 NAIL INFECTION 37 0.0258
27 BREAST NEOPLASM 26 0.0252
28 MILIA 9 0.0248
29 RADIATION NECROSIS 14 0.0244
30 METASTASES TO BREAST 8 0.0241
31 METASTASES TO CHEST WALL 8 0.0231
32 METASTASES TO LYMPH NODES 151 0.0224
33 PIK3CA-ACTIVATED MUTATION 7 0.0211
34 STENT OCCLUSION 11 0.0207
35 ONYCHOLYSIS 31 0.0198
36 JOINT ANKYLOSIS 11 0.0194
37 METASTASES TO LUNG 203 0.0176
38 SUBCLAVIAN VEIN THROMBOSIS 19 0.0167
39 VASCULAR DEVICE INFECTION 74 0.0163
40 SKIN TOXICITY 90 0.0159
41 BONE MARROW INFILTRATION 6 0.0155
42 DERMATITIS ACNEIFORM 94 0.0154
43 METASTASES TO SPINE 51 0.0152
44 GASTROINTESTINAL TOXICITY 72 0.0150
45 BRAIN CANCER METASTATIC 10 0.0145
46 HYPOCAPNIA 6 0.0144
47 METASTASES TO LIVER 247 0.0140
48 BILIARY DILATATION 20 0.0136
49 NAIL DISORDER 116 0.0132
50 INVASIVE DUCTAL BREAST CARCINOMA 36 0.0132
51 EJECTION FRACTION ABNORMAL 16 0.0131
52 BREAST CANCER RECURRENT 40 0.0127
53 GASTRIC NEOPLASM 8 0.0126
54 METASTASES TO BONE 206 0.0125
55 INGROWING NAIL 29 0.0123
56 GASTROINTESTINAL BACTERIAL INFECTION 14 0.0122
57 ONYCHOMADESIS 51 0.0121
58 NAIL BED DISORDER 5 0.0117
59 EJECTION FRACTION DECREASED 181 0.0116
60 RETROPERITONEAL LYMPHADENOPATHY 6 0.0114
61 BONE CANCER METASTATIC 6 0.0113
62 PALMAR ERYTHEMA 13 0.0113
63 LIP ULCERATION 13 0.0111
64 OROPHARYNGEAL CANDIDIASIS 10 0.0110
65 METASTASES TO MENINGES 25 0.0110
66 BRAIN OPERATION 25 0.0109
67 SOFT TISSUE DISORDER 12 0.0108
68 PYOGENIC GRANULOMA 5 0.0107
69 MALIGNANT PLEURAL EFFUSION 18 0.0107
70 BRONCHITIS VIRAL 7 0.0104
71 COMPUTERISED TOMOGRAM THORAX ABNORMAL 7 0.0102
72 BILE DUCT OBSTRUCTION 19 0.0100
73 METASTASIS 69 0.0097
74 METASTASES TO PLEURA 10 0.0095
75 INTRACRANIAL MASS 9 0.0095
76 NASAL ULCER 15 0.0094
77 HEPATIC CANCER METASTATIC 8 0.0093
78 CARBOHYDRATE ANTIGEN 15-3 INCREASED 7 0.0092
79 MALIGNANT ASCITES 7 0.0091
80 METASTATIC NEOPLASM 39 0.0090
81 LYMPHANGITIS 7 0.0087
82 RECURRENT CANCER 35 0.0086
83 CARDIOTOXICITY 76 0.0085
84 DISEASE PROGRESSION 1007 0.0085
85 ONYCHOCLASIS 58 0.0084
86 VASOGENIC CEREBRAL OEDEMA 6 0.0083
87 TUMOUR MARKER INCREASED 40 0.0083
88 VARICOSE VEIN 43 0.0083
89 SKIN FISSURES 158 0.0081
90 BRAIN NEOPLASM 74 0.0080
91 RADIATION SKIN INJURY 9 0.0078
92 MUCOSAL INFLAMMATION 199 0.0076
93 INTERVERTEBRAL DISC SPACE NARROWING 6 0.0074
94 HYPERBILIRUBINAEMIA 77 0.0074
95 AXILLARY PAIN 11 0.0074
96 CEREBRAL CYST 5 0.0073
97 BRAIN OEDEMA 89 0.0070
98 OSTEOSCLEROSIS 11 0.0070
99 ORTHOSTATIC INTOLERANCE 5 0.0070
100 PLEURAL FIBROSIS 7 0.0069
101 BREAST DISORDER 14 0.0069
102 CEREBRAL VASOCONSTRICTION 5 0.0068
103 PARAPARESIS 12 0.0067
104 BLOOD BILIRUBIN INCREASED 181 0.0067
105 DYSCHEZIA 20 0.0065
106 ANOREXIA 84 0.0065
107 METASTASES TO ADRENALS 6 0.0065
108 CHEILITIS 35 0.0065
109 DIARRHOEA 4173 0.0065
110 JAUNDICE CHOLESTATIC 22 0.0062
111 ABDOMINAL SYMPTOM 5 0.0062
112 CARCINOEMBRYONIC ANTIGEN INCREASED 12 0.0062
113 NEOPLASM RECURRENCE 21 0.0062
114 STOMATITIS 373 0.0061
115 RADIATION PNEUMONITIS 13 0.0061
116 PYURIA 6 0.0061
117 BRAIN NEOPLASM MALIGNANT 27 0.0060
118 HAEMATOTOXICITY 57 0.0060
119 LEFT VENTRICULAR DYSFUNCTION 40 0.0060
120 BILE DUCT STENOSIS 7 0.0058
121 ERYSIPELAS 29 0.0058
122 MASTECTOMY 10 0.0057
123 PERIPHERAL MOTOR NEUROPATHY 8 0.0057
124 DRUG TOLERANCE DECREASED 16 0.0057
125 HOSPICE CARE 56 0.0057
126 MALIGNANT NEOPLASM PROGRESSION 565 0.0055
127 HEPATIC NEOPLASM 18 0.0055
128 SECOND PRIMARY MALIGNANCY 45 0.0054
129 LYMPHOEDEMA 37 0.0053
130 CHAPPED LIPS 23 0.0053
131 BONE LESION 19 0.0053
132 PALLIATIVE CARE 8 0.0052
133 LIP PAIN 15 0.0052
134 RASH PUSTULAR 38 0.0052
135 INTRACRANIAL PRESSURE INCREASED 29 0.0052
136 ONCOLOGIC COMPLICATION 5 0.0052
137 HYPERTROPHIC CARDIOMYOPATHY 8 0.0052
138 BILIARY COLIC 15 0.0052
139 PERFORMANCE STATUS DECREASED 24 0.0051
140 THROMBOCYTOPENIC PURPURA 7 0.0051
141 JAUNDICE 135 0.0050
142 ENTERITIS 32 0.0050
143 ALVEOLITIS 7 0.0050
144 CATHETER RELATED INFECTION 5 0.0049
145 HEPATOTOXICITY 110 0.0049
146 OSTEOLYSIS 10 0.0049
147 MOUTH ULCERATION 101 0.0048
148 NASAL INFLAMMATION 5 0.0047
149 RADIOTHERAPY 9 0.0047
150 HEPATIC INFECTION 6 0.0047
151 BLOOD BILIRUBIN ABNORMAL 6 0.0047
152 BONE NEOPLASM 5 0.0046
153 NAIL DISCOLOURATION 18 0.0046
154 THROMBOSIS IN DEVICE 15 0.0046
155 ORAL INTAKE REDUCED 11 0.0045
156 NAIL GROWTH ABNORMAL 5 0.0045
157 LUNG INFILTRATION 40 0.0045
158 NEOPLASM 52 0.0045
159 POLYMYOSITIS 8 0.0045
160 HYPOKALAEMIA 207 0.0045
161 DEVICE RELATED SEPSIS 9 0.0045
162 URETERIC OBSTRUCTION 6 0.0044
163 MUCOUS MEMBRANE DISORDER 6 0.0044
164 EFFUSION 6 0.0044
165 CUSHINGOID 14 0.0044
166 GRANULOCYTE COUNT DECREASED 8 0.0043
167 PERIPHERAL SENSORY NEUROPATHY 25 0.0043
168 CHOLANGITIS 26 0.0042
169 EXPOSED BONE IN JAW 9 0.0041
170 INVESTIGATION 13 0.0041
171 HEPATIC CYST 14 0.0041
172 ENTERITIS INFECTIOUS 7 0.0041
173 LIP DISCOLOURATION 5 0.0040
174 MUSCLE CONTRACTURE 8 0.0039
175 ASPARTATE AMINOTRANSFERASE ABNORMAL 6 0.0039
176 DEHYDRATION 525 0.0039
177 METASTATIC MALIGNANT MELANOMA 9 0.0039
178 PIGMENTATION DISORDER 24 0.0039
179 NEOPLASM PROGRESSION 132 0.0038
180 ALANINE AMINOTRANSFERASE ABNORMAL 8 0.0038
181 CANDIDA INFECTION 64 0.0038
182 LOBAR PNEUMONIA 7 0.0038
183 SKIN MASS 25 0.0037
184 ARTERIOSPASM CORONARY 15 0.0037
185 ADENOCARCINOMA OF COLON 7 0.0037
186 VENTRICULAR HYPOKINESIA 12 0.0037
187 LACERATION 35 0.0037
188 HEPATIC LESION 16 0.0037
189 CREPITATIONS 11 0.0037
190 OROPHARYNGEAL BLISTERING 6 0.0037
191 FAECES PALE 8 0.0036
192 METASTASES TO PERITONEUM 9 0.0036
193 GLIOBLASTOMA 6 0.0035
194 LUNG NEOPLASM 15 0.0035
195 PURULENT DISCHARGE 15 0.0035
196 NEUTROPENIA 475 0.0035
197 SENSITIVITY OF TEETH 6 0.0035
198 PLEURAL EFFUSION 211 0.0035
199 CHANGE OF BOWEL HABIT 7 0.0034
200 FEBRILE NEUTROPENIA 224 0.0034
201 IMPETIGO 5 0.0034
202 DYSAESTHESIA 10 0.0033
203 PERICARDIAL EFFUSION 75 0.0032
204 OCULAR ICTERUS 14 0.0032
205 BREAST CANCER 301 0.0032
206 SKIN HYPERTROPHY 9 0.0032
207 ATYPICAL FEMUR FRACTURE 9 0.0032
208 COMPRESSION FRACTURE 17 0.0032
209 HYPERTRANSAMINASAEMIA 22 0.0032
210 ORTHOPNOEA 10 0.0031
211 ILEUS PARALYTIC 14 0.0031
212 PSEUDOMEMBRANOUS COLITIS 7 0.0031
213 CANCER PAIN 8 0.0031
214 ORAL PAIN 69 0.0031
215 HYPERAESTHESIA 25 0.0030
216 EXFOLIATIVE RASH 8 0.0030
217 HEPATIC FUNCTION ABNORMAL 113 0.0030
218 SKIN DISCOLOURATION 139 0.0030
219 BILIRUBIN CONJUGATED INCREASED 7 0.0030
220 TEMPOROMANDIBULAR JOINT SYNDROME 8 0.0030
221 SKIN ULCER 77 0.0030
222 DRY SKIN 397 0.0030
223 TONGUE ULCERATION 10 0.0030
224 COLORECTAL CANCER METASTATIC 7 0.0030
225 CARDIAC TAMPONADE 14 0.0029
226 LIP BLISTER 8 0.0029
227 ALANINE AMINOTRANSFERASE INCREASED 179 0.0029
228 SKIN HYPERPIGMENTATION 25 0.0029
229 APHAGIA 14 0.0029
230 LEFT VENTRICULAR FAILURE 10 0.0029
231 RASH VESICULAR 14 0.0029
232 ASCITES 85 0.0029
233 NEUROTOXICITY 50 0.0029
234 POLYNEUROPATHY 34 0.0028
235 NEUTROPHIL COUNT ABNORMAL 8 0.0028
236 IRON DEFICIENCY ANAEMIA 26 0.0028
237 UTERINE HAEMORRHAGE 12 0.0028
238 HEPATIC PAIN 12 0.0028
239 HEPATIC ENZYME ABNORMAL 14 0.0028
240 PNEUMOMEDIASTINUM 5 0.0028
241 CENTRAL NERVOUS SYSTEM LESION 38 0.0028
242 DYSPNOEA AT REST 8 0.0028
243 PATHOLOGICAL FRACTURE 14 0.0028
244 HYPERTRIGLYCERIDAEMIA 16 0.0027
245 CONDUCTION DISORDER 5 0.0027
246 AORTIC ARTERIOSCLEROSIS 7 0.0027
247 ADENOCARCINOMA 6 0.0027
248 HYPERURICAEMIA 11 0.0027
249 ELECTROLYTE IMBALANCE 31 0.0027
250 OSTEONECROSIS OF JAW 66 0.0027
251 CLOSTRIDIAL INFECTION 9 0.0027
252 MITRAL VALVE INCOMPETENCE 30 0.0026
253 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
254 GRANULOMA 9 0.0026
255 LEUKOPENIA 130 0.0026
256 ASPARTATE AMINOTRANSFERASE INCREASED 138 0.0026
257 HAEMANGIOMA 6 0.0026
258 NEUROLOGICAL DECOMPENSATION 6 0.0026
259 VOMITING 1211 0.0026
260 SKIN WRINKLING 7 0.0026
261 HYPOALBUMINAEMIA 20 0.0026
262 GAMMA-GLUTAMYLTRANSFERASE INCREASED 57 0.0026
263 PNEUMONITIS 70 0.0026
264 THROMBOPHLEBITIS 9 0.0026
265 PULMONARY MASS 38 0.0025
266 RASH GENERALISED 66 0.0025
267 TONGUE DISCOLOURATION 11 0.0025
268 MUCOSAL DRYNESS 5 0.0025
269 BREAST CANCER STAGE IV 7 0.0025
270 RASH 1062 0.0024
271 EMBOLISM 20 0.0024
272 NEUROPATHY PERIPHERAL 228 0.0024
273 EPISTAXIS 177 0.0024
274 EXCORIATION 6 0.0024
275 LOCAL SWELLING 41 0.0023
276 DERMATITIS 49 0.0023
277 BLISTER 131 0.0023
278 APHTHOUS ULCER 18 0.0023
279 MOUTH HAEMORRHAGE 17 0.0023
280 SPINAL CORD COMPRESSION 9 0.0023
281 EPIGASTRIC DISCOMFORT 9 0.0023
282 VENOUS THROMBOSIS 9 0.0023
283 CEREBELLAR SYNDROME 5 0.0023
284 ATELECTASIS 22 0.0023
285 DIASTOLIC DYSFUNCTION 7 0.0023
286 CANDIDIASIS 9 0.0022
287 DECREASED APPETITE 519 0.0022
288 NASAL DRYNESS 14 0.0022
289 HYPOCALCAEMIA 42 0.0022
290 HYDROCEPHALUS 12 0.0022
291 ORAL FUNGAL INFECTION 6 0.0022
292 CELLULITIS 109 0.0022
293 SKIN LESION 59 0.0021
294 MENOPAUSAL SYMPTOMS 5 0.0021
295 DEVICE RELATED INFECTION 33 0.0021
296 C-REACTIVE PROTEIN INCREASED 78 0.0021
297 TRICUSPID VALVE INCOMPETENCE 17 0.0021
298 STOMACH DISCOMFORT 11 0.0021
299 BLOOD POTASSIUM DECREASED 64 0.0021
300 ACUTE MYELOID LEUKAEMIA 33 0.0021
301 TENDERNESS 22 0.0021
302 CYTOLYTIC HEPATITIS 7 0.0021
303 NEUTROPENIC SEPSIS 15 0.0021
304 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
305 MONOPLEGIA 9 0.0021
306 BONE CANCER 9 0.0021
307 LIVER FUNCTION TEST ABNORMAL 60 0.0021
308 ELECTROCARDIOGRAM QT PROLONGED 74 0.0021
309 HEPATIC FAILURE 62 0.0021
310 CARDIOPULMONARY FAILURE 8 0.0020
311 WOUND SECRETION 8 0.0020
312 NAUSEA 1616 0.0020
313 TRANSAMINASES INCREASED 45 0.0020
314 EATING DISORDER 43 0.0020
315 BONE MARROW FAILURE 41 0.0020
316 URINARY TRACT DISORDER 9 0.0020
317 HYPERCAPNIA 6 0.0020
318 GASTROENTERITIS 29 0.0020
319 LOCALISED INFECTION 48 0.0020
320 SUDDEN DEATH 21 0.0020
321 SKIN DISORDER 66 0.0020
322 THROMBOCYTOPENIA 221 0.0020
323 SKIN EXFOLIATION 165 0.0020
324 PHLEBITIS 10 0.0020
325 NEOPLASM MALIGNANT 129 0.0019
326 FAILURE TO THRIVE 10 0.0019
327 DRUG TOXICITY 26 0.0019
328 SKIN HAEMORRHAGE 28 0.0019
329 DYSPEPSIA 184 0.0019
330 SKIN EROSION 6 0.0019
331 LOOSE TOOTH 6 0.0019
332 VULVOVAGINAL DRYNESS 6 0.0019
333 ILEUS 23 0.0018
334 SKIN LACERATION 20 0.0018
335 LYMPHADENOPATHY 65 0.0018
336 CARDIOMYOPATHY 27 0.0018
337 ONYCHOMYCOSIS 8 0.0018
338 FAECES SOFT 13 0.0018
339 LUNG CONSOLIDATION 5 0.0018
340 CONVULSION 102 0.0018
341 BLOOD TEST ABNORMAL 25 0.0018
342 ATAXIA 21 0.0018
343 LIP DRY 16 0.0018
344 OESOPHAGEAL STENOSIS 5 0.0018
345 ABDOMINAL HERNIA 8 0.0018
346 SCAB 20 0.0018
347 CACHEXIA 9 0.0017
348 DUODENAL ULCER PERFORATION 13 0.0017
349 DYSPHAGIA 165 0.0017
350 SKIN ATROPHY 10 0.0017
351 BLOOD CREATININE ABNORMAL 6 0.0017
352 LUNG CANCER METASTATIC 5 0.0017
353 GASTROINTESTINAL NECROSIS 5 0.0017
354 YELLOW SKIN 8 0.0017
355 DUODENAL ULCER 12 0.0017
356 SKIN TIGHTNESS 8 0.0017
357 BREAST CANCER STAGE III 11 0.0017
358 DEATH 1463 0.0017
359 ILL-DEFINED DISORDER 103 0.0017
360 GENERAL PHYSICAL HEALTH DETERIORATION 196 0.0017
361 ANORECTAL DISCOMFORT 9 0.0017
362 ACNE 128 0.0017
363 FATIGUE 1309 0.0017
364 RASH PRURITIC 91 0.0017
365 GINGIVITIS 9 0.0017
366 AORTIC VALVE INCOMPETENCE 7 0.0016
367 ERYTHEMA 336 0.0016
368 DRUG ADMINISTRATION ERROR 50 0.0016
369 HEPATOMEGALY 16 0.0016
370 LIVER DISORDER 72 0.0016
371 NECROSIS 9 0.0016
372 CHOLESTASIS 31 0.0016
373 ASTHENIA 607 0.0016
374 MULTIPLE-DRUG RESISTANCE 5 0.0016
375 INTERSTITIAL LUNG DISEASE 78 0.0016
376 DIARRHOEA HAEMORRHAGIC 15 0.0016
377 PNEUMOTHORAX 25 0.0016
378 MASS 22 0.0016
379 HYPERTHERMIA 12 0.0016
380 AMMONIA INCREASED 8 0.0016
381 PROCTALGIA 10 0.0016
382 CEREBRAL ISCHAEMIA 8 0.0016
383 RALES 9 0.0015
384 METABOLIC DISORDER 9 0.0015
385 PORTAL VEIN THROMBOSIS 5 0.0015
386 SENSATION OF HEAVINESS 6 0.0015
387 HEPATIC ENZYME INCREASED 105 0.0015
388 HYPOVOLAEMIA 9 0.0015
389 OEDEMA MOUTH 5 0.0015
390 ECZEMA 80 0.0015
391 PYREXIA 528 0.0015
392 ISCHAEMIA 7 0.0015
393 GASTRITIS 40 0.0015
394 OESOPHAGEAL PAIN 6 0.0015
395 NERVE COMPRESSION 14 0.0015
396 OTITIS MEDIA 5 0.0015
397 GINGIVAL PAIN 12 0.0015
398 ANAEMIA 287 0.0015
399 RESTLESSNESS 55 0.0015
400 OEDEMA PERIPHERAL 183 0.0015
401 RETCHING 32 0.0015
402 ABASIA 37 0.0015
403 BREAST MASS 10 0.0015
404 FUNGAL SKIN INFECTION 6 0.0015
405 DECUBITUS ULCER 12 0.0015
406 BONE PAIN 86 0.0015
407 PULMONARY THROMBOSIS 16 0.0015
408 REGURGITATION 5 0.0015
409 SPINAL STENOSIS 6 0.0015
410 NERVOUS SYSTEM DISORDER 45 0.0014
411 PULMONARY EMBOLISM 136 0.0014
412 RASH PAPULAR 32 0.0014
413 SKIN REACTION 20 0.0014
414 BUNDLE BRANCH BLOCK LEFT 6 0.0014
415 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
416 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
417 ABDOMINAL PAIN 328 0.0014
418 MYOCARDIAL ISCHAEMIA 16 0.0014
419 HYPERVENTILATION 8 0.0014
420 PAIN OF SKIN 37 0.0014
421 NEUTROPHIL COUNT DECREASED 56 0.0014
422 ADVERSE DRUG REACTION 122 0.0014
423 RASH MACULO-PAPULAR 30 0.0013
424 SEPSIS 150 0.0013
425 CARDIAC DYSFUNCTION 5 0.0013
426 LYMPHOPENIA 19 0.0013
427 SKIN INFECTION 15 0.0013
428 HYDRONEPHROSIS 10 0.0013
429 FOOD CRAVING 7 0.0013
430 OEDEMA 72 0.0013
431 WEIGHT DECREASED 370 0.0013
432 FRACTURE 25 0.0013
433 PHARYNGOLARYNGEAL PAIN 7 0.0013
434 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
435 SENSORY DISTURBANCE 21 0.0013
436 CLAVICLE FRACTURE 5 0.0013
437 ANAL FISSURE 7 0.0013
438 DROOLING 9 0.0013
439 LOCALISED OEDEMA 6 0.0013
440 HYPOMAGNESAEMIA 18 0.0013
441 ORAL CANDIDIASIS 17 0.0013
442 PELVIC FRACTURE 10 0.0013
443 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
444 MYOPATHY 11 0.0013
445 HYPERKERATOSIS 7 0.0013
446 MUSCLE ATROPHY 16 0.0013
447 NASAL DISCOMFORT 10 0.0013
448 HYPOPHAGIA 32 0.0013
449 RENAL FAILURE ACUTE 53 0.0012
450 HEPATIC STEATOSIS 23 0.0012
451 DYSGEUSIA 91 0.0012
452 CARDIOMEGALY 15 0.0012
453 ENTEROCOLITIS 7 0.0012
454 ORGANISING PNEUMONIA 6 0.0012
455 GASTROINTESTINAL PERFORATION 5 0.0012
456 LACRIMATION INCREASED 36 0.0012
457 CARDIAC FAILURE 95 0.0012
458 CONSTIPATION 258 0.0012
459 LIVER INJURY 29 0.0012
460 LIP OEDEMA 5 0.0012
461 LIPASE INCREASED 9 0.0012
462 ODYNOPHAGIA 7 0.0012
463 FEMORAL NECK FRACTURE 6 0.0012
464 HEPATITIS B 7 0.0012
465 GLOSSODYNIA 26 0.0012
466 ADVERSE EVENT 107 0.0012
467 ENCEPHALITIS 8 0.0012
468 THERAPY PARTIAL RESPONDER 18 0.0012
469 FOETAL GROWTH RESTRICTION 7 0.0012
470 RASH ERYTHEMATOUS 55 0.0011
471 NO THERAPEUTIC RESPONSE 14 0.0011
472 PARTIAL SEIZURES 6 0.0011
473 HYPOAESTHESIA 171 0.0011
474 SPINAL OSTEOARTHRITIS 10 0.0011
475 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
476 OLIGURIA 7 0.0011
477 BREAST PAIN 12 0.0011
478 RETINAL HAEMORRHAGE 8 0.0011
479 LUNG DISORDER 55 0.0011
480 WHITE BLOOD CELL COUNT DECREASED 121 0.0011
481 DISEASE RECURRENCE 53 0.0011
482 HYPOXIA 39 0.0011
483 MYELODYSPLASTIC SYNDROME 16 0.0011
484 LEUKOCYTOSIS 20 0.0011
485 PAIN IN EXTREMITY 324 0.0011
486 GINGIVAL BLEEDING 15 0.0011
487 OESOPHAGITIS 12 0.0011
488 HICCUPS 9 0.0011
489 IMPAIRED HEALING 36 0.0011
490 WOUND INFECTION 12 0.0011
491 NONSPECIFIC REACTION 6 0.0011
492 PERIPHERAL COLDNESS 15 0.0011
493 DEEP VEIN THROMBOSIS 70 0.0011
494 RENAL FUNCTION TEST ABNORMAL 5 0.0011
495 PANCYTOPENIA 60 0.0011
496 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
497 ERYTHEMA MULTIFORME 10 0.0011
498 HEMIPARESIS 18 0.0011
499 DYSPNOEA EXERTIONAL 40 0.0011
500 NEUTROPHILIA 6 0.0011
501 BREAST CANCER FEMALE 28 0.0010
502 PHARYNGITIS 13 0.0010
503 EPILEPSY 32 0.0010
504 CARDIAC FAILURE CONGESTIVE 84 0.0010
505 BLOOD MAGNESIUM DECREASED 9 0.0010
506 EXERCISE TOLERANCE DECREASED 6 0.0010
507 MULTI-ORGAN FAILURE 18 0.0010
508 FAECAL INCONTINENCE 5 0.0010
509 BLOOD URIC ACID INCREASED 6 0.0010
510 PYELONEPHRITIS 9 0.0010
511 MUSCULOSKELETAL CHEST PAIN 16 0.0010
512 DIZZINESS POSTURAL 10 0.0010
513 PAIN IN JAW 29 0.0010
514 PARAESTHESIA 161 0.0010
515 TUMOUR LYSIS SYNDROME 9 0.0010
516 DECREASED INTEREST 6 0.0010
517 DRUG RESISTANCE 26 0.0010
518 HYPONATRAEMIA 57 0.0010
519 FACIAL PAIN 9 0.0010
520 COLITIS 38 0.0010
521 FLUID INTAKE REDUCED 5 0.0010
522 DERMATITIS EXFOLIATIVE 5 0.0010
523 BLOOD DISORDER 8 0.0010
524 NODULE 13 0.0010
525 RHINITIS 8 0.0010
526 DYSPNOEA 561 0.0010
527 BURSITIS 12 0.0010
528 PULMONARY CONGESTION 13 0.0010
529 ABDOMINAL PAIN UPPER 203 0.0010
530 MALNUTRITION 11 0.0010
531 COUGH 275 0.0010
532 HAEMORRHOIDS 19 0.0010
533 HYPERCALCAEMIA 12 0.0010
534 HAIR DISORDER 8 0.0010
535 CONJUNCTIVITIS 18 0.0010
536 LUNG INFECTION 15 0.0010
537 PRURITUS 369 0.0010
538 PERICARDITIS 16 0.0010
539 RED BLOOD CELL COUNT DECREASED 27 0.0009
540 HERPES ZOSTER 54 0.0009
541 PULMONARY OEDEMA 42 0.0009
542 FLATULENCE 53 0.0009
543 TREATMENT NONCOMPLIANCE 51 0.0009
544 CHROMATURIA 21 0.0009
545 BACTERAEMIA 11 0.0009
546 PRURITUS GENERALISED 20 0.0009
547 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
548 VITAMIN D DEFICIENCY 9 0.0009
549 DRUG INTOLERANCE 89 0.0009
550 CHILLS 108 0.0009
551 BLOOD CREATININE INCREASED 60 0.0009
552 INFECTION 133 0.0009
553 DRY MOUTH 74 0.0009
554 PHOTOSENSITIVITY REACTION 15 0.0009
555 INTESTINAL ISCHAEMIA 5 0.0009
556 BLOOD SODIUM DECREASED 17 0.0009
557 TERMINAL STATE 6 0.0009
558 DYSURIA 33 0.0009
559 SMALL INTESTINAL OBSTRUCTION 11 0.0009
560 INFLAMMATION 46 0.0009
561 FREQUENT BOWEL MOVEMENTS 24 0.0009
562 ULCER HAEMORRHAGE 6 0.0009
563 OSTEOMYELITIS 16 0.0009
564 BLOOD ALBUMIN DECREASED 7 0.0009
565 CIRCULATORY COLLAPSE 15 0.0009
566 PELVIC PAIN 16 0.0009
567 HYPERGLYCAEMIA 32 0.0009
568 BONE DISORDER 16 0.0009
569 GRANULOCYTOPENIA 5 0.0009
570 ATRIAL FLUTTER 7 0.0009
571 HAEMATEMESIS 22 0.0009
572 HAIR GROWTH ABNORMAL 6 0.0009
573 PRESYNCOPE 21 0.0009
574 PLATELET COUNT DECREASED 92 0.0009
575 HEPATIC ENCEPHALOPATHY 8 0.0009
576 DEFAECATION URGENCY 6 0.0009
577 ABNORMAL FAECES 7 0.0009
578 PULMONARY TOXICITY 6 0.0008
579 SPINAL COMPRESSION FRACTURE 7 0.0008
580 THERMAL BURN 6 0.0008
581 HEMIPLEGIA 7 0.0008
582 CHOLECYSTITIS 10 0.0008
583 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
584 BACK PAIN 193 0.0008
585 TONGUE DISORDER 6 0.0008
586 TOOTHACHE 15 0.0008
587 HYPOKINESIA 12 0.0008
588 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
589 HAIR TEXTURE ABNORMAL 11 0.0008
590 UTERINE LEIOMYOMA 6 0.0008
591 QUALITY OF LIFE DECREASED 11 0.0008
592 ORAL DISORDER 6 0.0008
593 GASTROINTESTINAL PAIN 9 0.0008
594 PULMONARY HYPERTENSION 17 0.0008
595 DENTAL CARIES 9 0.0008
596 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
597 ALOPECIA 159 0.0008
598 TACHYPNOEA 11 0.0008
599 GENERALISED OEDEMA 10 0.0008
600 HYPERSOMNIA 23 0.0008
601 INTESTINAL PERFORATION 9 0.0008
602 RASH MACULAR 28 0.0008
603 BLOOD CALCIUM DECREASED 9 0.0008
604 THROMBOSIS 64 0.0008
605 TOXIC SKIN ERUPTION 8 0.0008
606 CHOLELITHIASIS 26 0.0008
607 MUSCULAR WEAKNESS 90 0.0008
608 OSTEOPENIA 12 0.0008
609 COORDINATION ABNORMAL 11 0.0008
610 WOUND 22 0.0008
611 CYSTITIS 25 0.0008
612 BODY TEMPERATURE INCREASED 16 0.0008
613 HAEMOGLOBIN ABNORMAL 5 0.0008
614 MALAISE 339 0.0008
615 DYSPHONIA 45 0.0008
616 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
617 TOOTH DISORDER 17 0.0008
618 TRANSFUSION 8 0.0008
619 FOLLICULITIS 8 0.0008
620 PARAESTHESIA ORAL 11 0.0008
621 BEDRIDDEN 10 0.0008
622 DYSGRAPHIA 5 0.0008
623 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
624 HAEMATOCRIT DECREASED 15 0.0008
625 RENAL CYST 6 0.0008
626 MENINGITIS 5 0.0007
627 GASTROOESOPHAGEAL REFLUX DISEASE 60 0.0007
628 CHEST PAIN 138 0.0007
629 THERAPEUTIC RESPONSE DECREASED 45 0.0007
630 BRONCHIECTASIS 5 0.0007
631 MUSCLE DISORDER 6 0.0007
632 VERTIGO 45 0.0007
633 ABDOMINAL DISTENSION 77 0.0007
634 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
635 LIMB INJURY 20 0.0007
636 DIZZINESS 367 0.0007
637 ASPHYXIA 6 0.0007
638 ABDOMINAL DISCOMFORT 123 0.0007
639 PRODUCTIVE COUGH 35 0.0007
640 APHASIA 22 0.0007
641 GAIT DISTURBANCE 139 0.0007
642 ERUCTATION 14 0.0007
643 THROMBOTIC MICROANGIOPATHY 7 0.0007
644 ORAL HERPES 14 0.0007
645 BLOOD UREA INCREASED 12 0.0007
646 EXTRASYSTOLES 5 0.0007
647 CARDIAC DISORDER 67 0.0007
648 PNEUMONIA 231 0.0007
649 DRY EYE 35 0.0007
650 CHOLECYSTECTOMY 8 0.0007
651 SKIN IRRITATION 32 0.0007
652 MUSCULOSKELETAL DISCOMFORT 12 0.0007
653 DIPLOPIA 18 0.0007
654 ULCER 11 0.0007
655 RESPIRATORY TRACT INFECTION 18 0.0007
656 SCIATICA 11 0.0007
657 NEUTROPHIL COUNT INCREASED 7 0.0007
658 SPLENOMEGALY 8 0.0007
659 RHINORRHOEA 44 0.0007
660 HYPOPHOSPHATAEMIA 5 0.0007
661 RECTAL HAEMORRHAGE 29 0.0007
662 HAEMATOCHEZIA 37 0.0007
663 MUSCLE SPASMS 123 0.0007
664 BURNING SENSATION 47 0.0007
665 GASTROINTESTINAL INFECTION 6 0.0007
666 STAPHYLOCOCCAL INFECTION 22 0.0007
667 INCONTINENCE 7 0.0007
668 PALPITATIONS 77 0.0007
669 EXOSTOSIS 6 0.0007
670 FACE OEDEMA 11 0.0007
671 CONFUSIONAL STATE 104 0.0006
672 GASTRIC DISORDER 22 0.0006
673 ASPIRATION 7 0.0006
674 CYANOSIS 10 0.0006
675 SINUS TACHYCARDIA 9 0.0006
676 URINARY TRACT INFECTION 108 0.0006
677 VISUAL ACUITY REDUCED 21 0.0006
678 PROTEINURIA 12 0.0006
679 SWELLING FACE 41 0.0006
680 GAIT INABILITY 21 0.0006
681 PANCREATITIS 33 0.0006
682 HEART RATE IRREGULAR 14 0.0006
683 MUSCLE TIGHTNESS 10 0.0006
684 INTENTIONAL PRODUCT USE ISSUE 54 0.0006
685 PHARMACEUTICAL PRODUCT COMPLAINT 16 0.0006
686 FEMUR FRACTURE 19 0.0006
687 ARRHYTHMIA 29 0.0006
688 HAEMORRHAGE 64 0.0006
689 MENTAL STATUS CHANGES 17 0.0006
690 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
691 COMA 29 0.0006
692 SWOLLEN TONGUE 19 0.0006
693 CARDIAC ARREST 50 0.0006
694 CHEST DISCOMFORT 62 0.0006
695 TREATMENT FAILURE 50 0.0006
696 OVARIAN CYST 6 0.0006
697 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
698 AMNESIA 39 0.0006
699 HOSPITALISATION 92 0.0006
700 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
701 MOVEMENT DISORDER 19 0.0006
702 MUSCULOSKELETAL PAIN 31 0.0006
703 MELAENA 13 0.0006
704 PHARYNGEAL OEDEMA 9 0.0006
705 STEVENS-JOHNSON SYNDROME 13 0.0006
706 PERIPHERAL SWELLING 90 0.0006
707 HYPOTENSION 117 0.0006
708 DYSSTASIA 17 0.0006
709 SYNCOPE 58 0.0006
710 GASTRIC ULCER 11 0.0006
711 MUSCULOSKELETAL DISORDER 11 0.0006
712 VENTRICULAR EXTRASYSTOLES 6 0.0006
713 EYE DISCHARGE 6 0.0006
714 TACHYCARDIA 51 0.0006
715 LETHARGY 33 0.0006
716 OROPHARYNGEAL PAIN 53 0.0006
717 VIRAL INFECTION 19 0.0006
718 CATARACT 34 0.0006
719 BALANCE DISORDER 49 0.0006
720 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
721 HAEMOGLOBIN DECREASED 58 0.0006
722 SURGERY 33 0.0006
723 TOOTH EXTRACTION 7 0.0006
724 RESPIRATORY FAILURE 41 0.0006
725 ANGINA PECTORIS 16 0.0006
726 HAEMOLYTIC ANAEMIA 5 0.0006
727 SKIN CANCER 12 0.0006
728 INTESTINAL OBSTRUCTION 21 0.0006
729 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
730 INSOMNIA 148 0.0006
731 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
732 FEELING HOT 34 0.0006
733 PHARYNGITIS STREPTOCOCCAL 6 0.0006
734 SPEECH DISORDER 29 0.0006
735 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
736 HEPATITIS 14 0.0005
737 RETINAL DETACHMENT 5 0.0005
738 INCREASED TENDENCY TO BRUISE 5 0.0005
739 HIATUS HERNIA 7 0.0005
740 COLON CANCER 8 0.0005
741 NECK PAIN 30 0.0005
742 BACTERIAL INFECTION 10 0.0005
743 DEFORMITY 5 0.0005
744 RIB FRACTURE 11 0.0005
745 HYPERSENSITIVITY 99 0.0005
746 HEADACHE 330 0.0005
747 SCAR 9 0.0005
748 PAIN 321 0.0005
749 THYROID DISORDER 8 0.0005
750 ABDOMINAL PAIN LOWER 13 0.0005
751 GASTROINTESTINAL DISORDER 46 0.0005
752 AMENORRHOEA 9 0.0005
753 SWELLING 48 0.0005
754 FUNGAL INFECTION 17 0.0005
755 LYMPHOCYTE COUNT DECREASED 9 0.0005
756 PRODUCT USE COMPLAINT 8 0.0005
757 DISORIENTATION 20 0.0005
758 HOT FLUSH 38 0.0005
759 ORAL DISCOMFORT 7 0.0005
760 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
761 FEELING COLD 14 0.0005
762 ABSCESS 8 0.0005
763 SPINAL FRACTURE 10 0.0005
764 DEAFNESS 13 0.0005
765 HAEMATURIA 17 0.0005
766 HEPATOCELLULAR INJURY 7 0.0005
767 DRY THROAT 5 0.0005
768 BLINDNESS 20 0.0005
769 RENAL FAILURE 65 0.0005
770 PANCREATITIS ACUTE 11 0.0005
771 PARALYSIS 7 0.0005
772 INITIAL INSOMNIA 5 0.0005
773 EAR DISCOMFORT 5 0.0005
774 THERAPY CESSATION 25 0.0005
775 TOXICITY TO VARIOUS AGENTS 82 0.0005
776 NASOPHARYNGITIS 89 0.0005
777 PERITONITIS 10 0.0005
778 SEPTIC SHOCK 21 0.0005
779 SOMNOLENCE 97 0.0005
780 LIP SWELLING 16 0.0005
781 COAGULOPATHY 8 0.0005
782 POLLAKIURIA 20 0.0005
783 PETECHIAE 5 0.0005
784 HEPATIC CIRRHOSIS 9 0.0005
785 DYSARTHRIA 18 0.0005
786 ACUTE MYOCARDIAL INFARCTION 14 0.0005
787 BLOOD URINE PRESENT 9 0.0005
788 HEAD INJURY 15 0.0005
789 RESPIRATORY DISTRESS 13 0.0005
790 HYPOTHYROIDISM 15 0.0005
791 IMMUNODEFICIENCY 7 0.0005
792 HAEMOPTYSIS 13 0.0005
793 HYPOAESTHESIA ORAL 7 0.0005
794 FAECES DISCOLOURED 10 0.0005
795 PLATELET COUNT INCREASED 6 0.0005
796 HEPATIC CANCER 11 0.0005
797 TOOTH INFECTION 6 0.0005
798 NEURALGIA 11 0.0005
799 UPPER LIMB FRACTURE 9 0.0005
800 SEIZURE 52 0.0004
801 SINUSITIS 46 0.0004
802 GALLBLADDER DISORDER 8 0.0004
803 PRODUCT USE IN UNAPPROVED INDICATION 111 0.0004
804 MYALGIA 76 0.0004
805 DRUG-INDUCED LIVER INJURY 14 0.0004
806 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
807 NEPHROPATHY TOXIC 5 0.0004
808 FISTULA 5 0.0004
809 SINUS CONGESTION 6 0.0004
810 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
811 GASTROENTERITIS VIRAL 8 0.0004
812 AGEUSIA 11 0.0004
813 OBESITY 7 0.0004
814 MYOCARDITIS 5 0.0004
815 HIP FRACTURE 14 0.0004
816 HUNGER 6 0.0004
817 EYELID OEDEMA 5 0.0004
818 EYE SWELLING 16 0.0004
819 MIDDLE INSOMNIA 8 0.0004
820 DRUG INEFFECTIVE 561 0.0004
821 SLEEP DISORDER 30 0.0004
822 INFUSION RELATED REACTION 28 0.0004
823 DRUG INTERACTION 67 0.0004
824 FOOT FRACTURE 8 0.0004
825 LOSS OF CONSCIOUSNESS 54 0.0004
826 OCULAR HYPERAEMIA 20 0.0004
827 BLOOD PRESSURE DECREASED 28 0.0004
828 BRONCHOSPASM 6 0.0004
829 LIVER FUNCTION TEST INCREASED 9 0.0004
830 MACULAR DEGENERATION 5 0.0004
831 HYPERLIPIDAEMIA 5 0.0004
832 POOR QUALITY SLEEP 9 0.0004
833 POST PROCEDURAL COMPLICATION 8 0.0004
834 RENAL IMPAIRMENT 35 0.0004
835 ACUTE RESPIRATORY FAILURE 8 0.0004
836 MENTAL IMPAIRMENT 10 0.0004
837 CYTOPENIA 5 0.0004
838 PNEUMONIA ASPIRATION 10 0.0004
839 DEPRESSED MOOD 21 0.0004
840 COLD SWEAT 7 0.0004
841 DRUG ERUPTION 7 0.0004
842 FEEDING DISORDER 8 0.0004
843 TINNITUS 18 0.0004
844 SHOCK 9 0.0004
845 LUNG NEOPLASM MALIGNANT 16 0.0004
846 COGNITIVE DISORDER 18 0.0004
847 INJURY 27 0.0004
848 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
849 ATRIAL FIBRILLATION 37 0.0004
850 IMMUNE SYSTEM DISORDER 5 0.0004
851 VISUAL IMPAIRMENT 47 0.0004
852 DISCOMFORT 23 0.0004
853 ARTHRALGIA 155 0.0004
854 URINARY INCONTINENCE 11 0.0004
855 HYPOGLYCAEMIA 18 0.0004
856 BLOOD POTASSIUM INCREASED 6 0.0004
857 RESPIRATORY DISORDER 11 0.0004
858 INCREASED APPETITE 7 0.0004
859 OSTEONECROSIS 12 0.0004
860 PULMONARY FIBROSIS 7 0.0004
861 BRONCHITIS 27 0.0004
862 JOINT SWELLING 44 0.0004
863 INFLUENZA LIKE ILLNESS 30 0.0004
864 HEART RATE INCREASED 36 0.0004
865 ANGIOEDEMA 16 0.0004
866 URINARY RETENTION 12 0.0004
867 HYPERTENSION 76 0.0004
868 CRYING 13 0.0004
869 KIDNEY INFECTION 7 0.0004
870 LIMB DISCOMFORT 11 0.0004
871 GASTRIC CANCER 9 0.0004
872 CARDIOVASCULAR DISORDER 9 0.0004
873 ORTHOSTATIC HYPOTENSION 6 0.0003
874 ANHEDONIA 9 0.0003
875 OFF LABEL USE 297 0.0003
876 TOOTH LOSS 7 0.0003
877 THIRST 6 0.0003
878 URTICARIA 56 0.0003
879 DEPRESSION 76 0.0003
880 MYELOSUPPRESSION 12 0.0003
881 MOOD ALTERED 9 0.0003
882 HYPOACUSIS 14 0.0003
883 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
884 VAGINAL HAEMORRHAGE 14 0.0003
885 RENAL DISORDER 15 0.0003
886 FALL 107 0.0003
887 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
888 VISION BLURRED 43 0.0003
889 EAR PAIN 6 0.0003
890 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
891 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
892 EYE DISORDER 10 0.0003
893 DISABILITY 6 0.0003
894 SINUS DISORDER 6 0.0003
895 ACCIDENTAL OVERDOSE 11 0.0003
896 MEMORY IMPAIRMENT 41 0.0003
897 FULL BLOOD COUNT DECREASED 6 0.0003
898 EYE PRURITUS 10 0.0003
899 FLUID RETENTION 15 0.0003
900 PALLOR 8 0.0003
901 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
902 THERAPY NON-RESPONDER 13 0.0003
903 CARDIO-RESPIRATORY ARREST 12 0.0003
904 CEREBRAL INFARCTION 7 0.0003
905 HYPERKALAEMIA 10 0.0003
906 ENCEPHALOPATHY 7 0.0003
907 ISCHAEMIC STROKE 5 0.0003
908 DRUG DOSE OMISSION 46 0.0003
909 TREMOR 46 0.0003
910 UNRESPONSIVE TO STIMULI 7 0.0003
911 LABORATORY TEST ABNORMAL 8 0.0003
912 CONTUSION 26 0.0003
913 MEDICATION ERROR 15 0.0003
914 AGRANULOCYTOSIS 5 0.0003
915 THROAT IRRITATION 12 0.0003
916 JOINT STIFFNESS 7 0.0003
917 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
918 PHOTOPHOBIA 5 0.0003
919 EMOTIONAL DISORDER 8 0.0003
920 THROAT TIGHTNESS 7 0.0003
921 RESPIRATORY ARREST 7 0.0003
922 ANXIETY 72 0.0003
923 DEMENTIA 7 0.0003
924 MYOCARDIAL INFARCTION 42 0.0002
925 NEPHROLITHIASIS 11 0.0002
926 PRODUCT USE ISSUE 45 0.0002
927 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
928 MOBILITY DECREASED 17 0.0002
929 ANAPHYLACTIC REACTION 13 0.0002
930 FEELING ABNORMAL 56 0.0002
931 INFLUENZA 26 0.0002
932 HAEMATOMA 6 0.0002
933 NERVOUSNESS 12 0.0002
934 EAR INFECTION 6 0.0002
935 BLOOD PRESSURE INCREASED 34 0.0002
936 COVID-19 39 0.0002
937 NASAL CONGESTION 13 0.0002
938 MOOD SWINGS 7 0.0002
939 PANIC ATTACK 8 0.0002
940 DIVERTICULITIS 6 0.0002
941 ROAD TRAFFIC ACCIDENT 9 0.0002
942 CEREBROVASCULAR ACCIDENT 36 0.0002
943 OSTEOARTHRITIS 9 0.0002
944 CONDITION AGGRAVATED 64 0.0002
945 EXPOSURE DURING PREGNANCY 13 0.0002
946 ACUTE KIDNEY INJURY 32 0.0002
947 WEIGHT INCREASED 46 0.0002
948 DRUG EFFECT DECREASED 11 0.0002
949 CORONARY ARTERY DISEASE 6 0.0002
950 THERAPY INTERRUPTED 14 0.0002
951 OXYGEN SATURATION DECREASED 11 0.0002
952 SKIN BURNING SENSATION 14 0.0002
953 WHEEZING 11 0.0002
954 MUSCULOSKELETAL STIFFNESS 16 0.0002
955 AGGRESSION 9 0.0002
956 UNDERDOSE 13 0.0002
957 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
958 HEART RATE DECREASED 6 0.0002
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
960 BRADYCARDIA 9 0.0002
961 PRODUCT QUALITY ISSUE 23 0.0002
962 DISTURBANCE IN ATTENTION 9 0.0002
963 ARTHRITIS 13 0.0002
964 EYE PAIN 9 0.0002
965 METABOLIC ACIDOSIS 5 0.0002
966 EYE IRRITATION 9 0.0002
967 PRODUCT DOSE OMISSION 10 0.0002
968 ASTHMA 17 0.0002
969 OSTEOPOROSIS 6 0.0001
970 OVERDOSE 31 0.0001
971 MIGRAINE 13 0.0001
972 HALLUCINATION 10 0.0001
973 HYPERHIDROSIS 17 0.0001
974 ARTHROPATHY 7 0.0001
975 ABORTION SPONTANEOUS 5 0.0001
976 DYSKINESIA 5 0.0001
977 INCORRECT DOSE ADMINISTERED 28 0.0001
978 NO ADVERSE EVENT 22 0.0001
979 FLUSHING 12 0.0001
980 EMOTIONAL DISTRESS 14 0.0001
981 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
982 BLOOD GLUCOSE INCREASED 21 0.0001
983 UNEVALUABLE EVENT 8 0.0001
984 BLOOD GLUCOSE DECREASED 5 0.0001
985 SUICIDAL IDEATION 9 0.0001
986 AGITATION 7 0.0001
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
988 DIABETES MELLITUS 6 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
990 COMPLETED SUICIDE 5 0.0001
991 ILLNESS 5 0.0000
992 INJECTION SITE PAIN 12 0.0000
993 PSORIASIS 5 0.0000
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
995 PRODUCT DOSE OMISSION ISSUE 8 0.0000